EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil

Raquel Curtinhas de Lima, Helver Gonçalves Dias iD, Thiara Manuele Alves de Souza, Débora Familiar-Macedo iD, Edcelha D'Athaide Ribeiro, Valmir Corrêa E Corrêa, Alex Pauvolid-Corrêa iD, Elzinandes Leal de Azeredo, Flávia Barreto Dos Santos iD

Pathogens · 2024

DOI: 10.3390/pathogens13060469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Raquel Curtinhas de Lima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: Orthobunyavirus, Antibodies, Viral, Chikungunya virus, Chikungunya Fever. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oropouche orthobunyavirus (OROV) is an arbovirus transmitted by midges that has been involved in outbreaks throughout Central and South America. In Brazil, human cases have been historically concentrated in the northern region of the country. Oropouche fever in humans range from mild clinical signs to rare neurological events, and is considered a neglected tropical disease in Brazil. Due to the clinical similarities to other arboviruses, such as chikungunya and dengue viruses, OROV infections are likely to be underreported. Chikungunya virus (CHIKV) cases in Brazil were first recognized in 2014 in the states of Amapá and Bahia in the north and northeast regions, respectively. Both OROV and CHIKV cause nonspecific symptoms, making clinical diagnosis difficult in a scenario of arbovirus cocirculation. Aiming to investigate OROV transmission during the CHIKV introduction in the state of Amapá located in the Brazilian Amazon, we conducted a retrospective molecular (RT-qPCR) and serological investigation in febrile cases (N = 166) collected between August 2014 and May 2015. All acute serum samples were negative for OROV RNA using RT-qPCR. However, neutralizing antibodies for OROV were detected using a plaque reduction neutralization test (PRNT90) in 10.24% (17/166) of the patients, with neutralizing antibody titers ranging from 20 to ≥640, suggesting the previous exposure of patients to OROV. Regarding CHIKV, recent exposure was confirmed by the detection of CHIKV RNA in 20.25% (33/163) of the patients and by the detection of anti-CHIKV IgM in 28.57% (44/154) of the patients. The additional detection of anti-CHIKV IgG in 12.58% (19/151) of the febrile patients suggests that some individuals had been previously exposed to CHIKV. Whether the OROV exposure reported here occurred prior or during the CHIKV circulation in Amapá, is unknown, but because those arboviral infections share similar clinical signs and symptoms, a silent circulation of enzootic arboviruses during the introduction of exotic arboviruses may occur, and highlights the importance of syndromic cases’ surveillance to arboviruses in Brazil.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrthobunyavirusAntibodies, ViralChikungunya virusChikungunya FeverHumansBrazilMaleFemaleAdultMiddle AgedAdolescentYoung AdultRetrospective StudiesBunyaviridae InfectionsChildFeverAgedChild, PreschoolAntibodies, NeutralizingRNA, ViralImmunoglobulin M

Stichwörter der Autor:innen

PRNTRT-qPCRarbovirussurveillance

Substanzen

Antibodies, ViralAntibodies, NeutralizingRNA, ViralImmunoglobulin M

Autor:innen und Institutionen

  • Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.
  • Laboratório Central/Amapa (LACEN/AP), Macapá 68908-530, Brazil.
  • Laboratório de Fronteira (LAFRON), Oiapoque 69980-000, Brazil.
  • Laboratório de Virologia Veterinária de Viçosa, Departamento de Veterinária, Universidade Federal de Viçosa (UFV), Viçosa 36570-900, Brazil.

ORCID-Profile: Helver Gonçalves Dias, Débora Familiar-Macedo, Alex Pauvolid-Corrêa, Flávia Barreto Dos Santos

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundação Oswaldo Cruz (Fiocruz), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
  • CNPq and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Zitieren

APA

de Lima, R. C., Dias, H. G., de Souza, T. M. A., Familiar-Macedo, D., Ribeiro, E. D., Corrêa, V. C. E., Pauvolid-Corrêa, A., de Azeredo, E. L., & Dos Santos, F. B. (2024). Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil. Pathogens. https://doi.org/10.3390/pathogens13060469

Vancouver

de Lima RC, Dias HG, de Souza TMA, Familiar-Macedo D, Ribeiro ED, Corrêa VCE, et al. Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil. Pathogens. 2024. doi:10.3390/pathogens13060469

BibTeX
@article{deLima2024,
  author = {de Lima, Raquel Curtinhas and Dias, Helver Gonçalves and de Souza, Thiara Manuele Alves and Familiar-Macedo, Débora and Ribeiro, Edcelha D'Athaide and Corrêa, Valmir Corrêa E and Pauvolid-Corrêa, Alex and de Azeredo, Elzinandes Leal and Dos Santos, Flávia Barreto},
  title = {Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13060469}
}
Kostenlos starten →